Clinical Trials Insight: 700016984
Phase of Trial: Phase I
Latest Information Update: 19 Apr 2007
At a glance
- Drugs PRX 07034 (Primary)
- Indications Cognition disorders; Obesity
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors EPIX Pharmaceuticals
- 19 Apr 2007 Results have been reported in an EPIX Pharmaceuticals media release.
- 19 Apr 2007 Status changed from initiated to completed
- 27 Oct 2006 New trial record.